Innovative Drug Development Solutions for Neurodegenerative Diseases
SeNostic is Revolutionising Neurodegenerative Disease Detection and Drug Discovery with Cutting-Edge Technology A SeNostic Company Presentation SeNostic aims to enhance
Read moreSeNostic is Revolutionising Neurodegenerative Disease Detection and Drug Discovery with Cutting-Edge Technology A SeNostic Company Presentation SeNostic aims to enhance
Read moreSanofi has announced a definitive agreement to acquire Blueprint Medicines, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and
Read moreAs we approach the midpoint of the 2020s, the pharmaceutical industry has undergone a radical digital transformation, driven by the
Read moreIn the vast landscape of pharmaceutical research and development, one significant challenge that researchers face is the availability of suitable
Read moreAntiinfectives Intelligence (Aii) offers a specialised oligodynamic testing service designed to evaluate the antimicrobial properties of silver spirals and similar
Read moreAntiinfectives Intelligence (Aii) offers Dynamic Integrity Testing services, a critical evaluation method to assess the integrity of multi-dose pharmaceutical containers
Read moreAntiinfectives Intelligence (Aii) offers cutting-edge Microbroth Dilution testing services, recognised as the gold standard for determining the Minimum Inhibitory Concentration
Read moreAntiinfectives Intelligence (Aii) offers top-tier Agar Dilution Testing services, a precise and reliable method for determining bacterial sensitivities to antibiotics
Read moreAntiinfectives Intelligence (Aii) offers state-of-the-art Time-Kill Assay services to evaluate the dynamic killing effects of antimicrobial agents. This advanced method
Read morePresident Donald Trump’s announcement of the $500 billion Stargate initiative marks a transformative moment for the pharmaceutical sector and healthcare
Read more